Chimeric Beta-Defensin Analogs, Including the Novel 3NI Analog, Display Salt-Resistant Antimicrobial Activity and Lack Toxicity in Human Epithelial Cell Lines

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00934-12